Liver cancer patients in India seeking advanced treatments including CAR-T cell therapy now have expanding access pathways through specialized oncology centers, clinical trial networks, and multidisciplinary tumor boards that evaluate eligibility for investigational therapies and established immunotherapy protocols. TL;DR India launched its first indigenous CAR-T therapy NexCAR19 in 2026, showing promising results in leukemia and lymphoma, though liver cancer applications rem